- PONS's Newsletter
- Posts
- Pioneering The Next Era of Chronic Care and Discovery
Pioneering The Next Era of Chronic Care and Discovery
The focus of the past 10 years has been on preventing readmissions, and now in the next 10 years, the focus will be on preventing admissions.
PONS leverages breakthrough AI to guide ultrasound usage by virtual care teams outside hospitals for continuous monitoring and triage. Our algorithms enhance imaging, extract insights, and integrate with clinical workflows - unlocking new paradigms.
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/3dff4727-7d2e-49b3-a68a-744a17860124/sonerh_In_the_style_of_a_award_winning_documantary_photograhpy__f9efb5d3-0bd2-41ce-ac29-612950667341.png)
Nurse visiting patient at home, performing ultrasound scan
PONS leverages breakthrough AI to guide ultrasound usage by virtual care teams outside hospitals for continuous monitoring and triage. Our algorithms enhance imaging, extract insights, and integrate with clinical workflows - unlocking new paradigms.
The PONS Difference:
Easy-to-follow scanning guidance for precise ultrasound by non-experts
Automated image enhancement produces quality comparable to hospital-grade systems
Real-time transmission, analysis and EHR integration for seamless collaboration
Patient-centered design using consumer devices and efficient workflows
Continual model optimization driven by real-world usage data at scale
Benefits for Health Systems:
Reduce ER overcrowding by 20-40% through remote care team triage
Uncover real-world progression data to reveal variability in disease presentation and treatment response
Population health analytics for data-driven prevention policy improvements
New value-based outpatient services powered by longitudinal patient insights
Optimize resources with doctors focused only on critical care needs
Value for Drug Development:
Real-world progression data provides vital contextual insights missing from trials
Illuminates disease pathways to identify future targets and biomarkers
Optimizes trial patient selection, dosing, and treatment comparisons
Enables validating therapies through post-launch monitoring
Discoveries and cost savings from unprecedented data accelerating R&D